SFGLC
ONCY

Stonebridge Financial Group, LLC/CA’s Oncolytics Biotech ONCY Stock Holding History

Stonebridge Financial Group, LLC/CA’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Buy
+21,061
New +$19.5K ﹤0.01% 309

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Stonebridge Financial Group, LLC/CA's ONCY Position: Q2 2026 in Review

Stonebridge Financial Group, LLC/CA opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 21,061 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #309 among its holdings.

55 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Stonebridge Financial Group, LLC/CA held 21,061 shares of Oncolytics Biotech worth $20K as of Q2 2026.
  • Oncolytics Biotech was a new Stonebridge Financial Group, LLC/CA position in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of Stonebridge Financial Group, LLC/CA's portfolio in Q2 2026, its #309 holding.
  • 55 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Stonebridge Financial Group, LLC/CA's 13F filing for Q2 2026, filed 13 Aug 2026.